Five recombinant fragments of human serum albumin - Tools for the characterization of the warfarin binding site

Protein Science

Volumn 9, Issue 8, 2000, Pages 1455-1465

  Dockal, Michael ^a   Chang, Martina ^a   Carter, Daniel C ^b   Rüker, Florian ^a  

^a UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

^b New Century Pharmaceuticals Incorporated   (United States)

Author keywords

Albumin; Circular dichroism; Fluorescence spectroscopy; Ligand binding; Warfarin

Indexed keywords

ALBUMIN; WARFARIN;

ARTICLE; BINDING SITE; CIRCULAR DICHROISM; DRUG BINDING; FLUORESCENCE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; ULTRAVIOLET SPECTROSCOPY;

EID: 0033842504     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.9.8.1455     Document Type: Article

References (53)

1. Mechanism by which warfarin binds to human serum albumin
2. Location and characterization of the warfarin binding site of human serum albumin
3. Binding of coumarin anticoagulants to human and bovine serum albumin
4. Structure of serum albumin
5. Fluorescence spectroscopy - A tool for studying drug interactions with biological systems
6. Solvent-accessible surfaces of proteins and nucleic acids
7. Fluorescence and protein structure
8. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites
9. The three recombinant domains of human serum albumin
10. Conformational transitions of the three recombinant domains of human serum albumin depending on pH
11. Cation-pi interactions in chemistry and biology: A new view of benzene, Phe, Tyr, and Trp
12. A comparative study of some physico-chemical properties of human serum albumin samples from different sources - I
13. Exposure of tryptophanyl residues in proteins
14. Exposure of tryptophanyl residues and protein dynamics
15. A general, wide-rage spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin
16. The location of drug binding sites in human serum albumin
17. The lone tryptophan residue of human serum albumin as part of the specific warfarin binding site
18. Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone
19. Calculation of protein extinction coefficients from amino acid sequence data
20. Removal of fatty acids from serum albumin by Lipidex 1000 chromatography
21. Influence of pH and electrolyte on the fluorescence of bovine serum albumin
22. Nature of the alteration of the fluorescence spectrum of bovine serum albumin produced by the binding of dodecyl sulfate
23. Atomic structure and chemistry of human serum albumin
24. Conformational changes in human serum albumin studied by fluorescence and absorption spectroscopy
25. Species differences of serum albumins: I. Drug binding sites
26. Molecular aspects of ligand binding to serum albumin
27. Relations between high-affinity binding sites of markers for binding regions on human serum albumin
28. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands
29. Structure and ligand binding properties of human serum albumin
30. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
31. Interaction of warfarin with human serum albumin
32. Partially folded state of the disulfide-reduced form of human serum albumin as an intermediate for reversible denaturation
33. Chiral separation mechanisms in protein-based HPLC columns
34. Fluorimetric analysis of the binding of warfarin to human serum albumin
35. Cation-pi interactions in aromatics of biological and medicinal interest: Electrostatic potential surfaces as a useful qualitative guide
36. A comparative study of the interaction of warfarin with human alpha 1- acid glycoprotein and human albumin
37. A comparison of drug binding sites on mammalian albumins
38. Familial dysalbuminemic byperthyroxinemia may result in altered warfarin pharmacokinetics
39. A constrained regularization method for inverting data represented by linear algebraic or integral equations
40. Contin: A general purpose constrained regularization program for inverting noisy linear algebraic and integral equations
41. Estimation of globular protein secondary structure from circular dichroism
42. Comparison of graphical procedures for estimating the intrinsic molar fluorescence of protein-bound drugs for drug-binding studies
43. Differences between bovine and human serum albumins: Binding isotherms, optical rotatory dispersion, viscosity, hydrogen ion titration, and fluorescence effects
44. Spectroscopic techniques in the study of protein binding
45. The characterization of two specific drug binding sites on human serum albumin
46. Further characterization of specific drug binding sites on human serum albumin
47. Crystal structure of human serum albumin at 2.5 resolution
48. Rigidity of human alpha-fetoprotein tertiary structure is under ligand control
49. Reversible ligand binding to human serum albumin
50. Temperature behaviour of human serum albumin
51. Concentration-dependent effects of fatty acids on warfarin binding to albumin
52. Characterization of site I on human serum albumin: Concept about the structure of a drug binding site